Manufacturing a vaccine for West Nile virus
Official title: Task V30: GMP Manufacturing of WNV Vaccine
Funded at Advanced Bioscience Laboratories, INC. · NIH-11091391 · Data updated 2026-11-12
This study is working on creating a new vaccine for West Nile virus to help protect people from the illness, and it aims to make sure the vaccine is safe and effective before it’s tested in patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | May 11, 2022 |
| Project end | March 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $591,316 |
| NIH project number | 272201800009I-P00004-759302200001-1 |
| Project ID | NIH-11091391 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research would include individuals at risk of West Nile virus infection, particularly those living in endemic areas.
✕Less likely to help
Patients who are not at risk of West Nile virus infection or those with contraindications to vaccination may not receive benefit from this research.
What this research studies
This research focuses on the development and manufacturing of a vaccine for West Nile virus (WNV), which includes planning, optimization, and compliance with regulatory standards for clinical trials. The project aims to produce vaccines and biologics that can be tested in early-phase clinical studies. Patients may benefit from the advancements in vaccine technology and the potential introduction of effective treatments for WNV. The research involves collaboration with regulatory bodies to ensure safety and efficacy.
Why it matters
Potential benefit: If successful, this research could lead to the development of a safe and effective vaccine for West Nile virus, improving public health outcomes.
How similar studies have gone: Other research has shown success in developing vaccines for similar infectious diseases, indicating a promising potential for this approach.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.